Testing version — LOERadar is in active testing. Features and data may change.
SYNERCID (QUINUPRISTIN; DALFOPRISTIN) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
SYNERCID
NDANot in Orange Book
QUINUPRISTIN; DALFOPRISTIN | N050747 | KING PHARMS
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 500MG
▴
INJECTABLE; INJECTION | Approved: Sep. 21, 1999
No patent or exclusivity listings for this strength.